EarSwitch Ltd.

EarSwitch Ltd. is a United Kingdom-based medical technology company focused on in-ear biometric sensing and control technology. Founded by clinician Dr Nick Gompertz, the company was born from his experiences seeing people with motor neurone disease (ALS) lose their ability to communicate. His initial idea was a non-intrusive, in-ear device that could help people with neurological impairments control devices by tensing a middle ear muscle. That early communications concept expanded into a broader platform when Gompertz discovered the ear's potential for capturing real-world health data from a site close to the eardrum. Today, EarSwitch develops a suite of in-ear biometric control and sensor technologies for a growing range of global applications. Its flagship offering is EarMetrics®, a suite of licensable in-ear biometrics hardware and technology designed to generate medical-grade insights that inform clinical decisions, empower personal health, and accelerate the development of new treatments. The company also describes the EarMetrics® Cloud, a responsible cloud architecture intended to securely store contextual, racially inclusive, and structured digital biomarkers, with applications spanning Hospital at Home, remote patient monitoring, in-hospital care, and clinical research. EarSwitch positions itself around a vision of redesigning the future of healthcare through in-ear experiences. Its stated goals include capturing credible and interoperable health data, enabling racially inclusive oximetry, and augmenting human-to-environment experiences. The company operates from its headquarters in Bristol with a team of 14 people, including doctors, scientists, developers, engineers, and industry experts. It is supported by academic, clinical, and commercial partners, including the NHS Clinical Entrepreneurs Programme, the Innovative Devices Access Pathway (IDAP), Praetura Ventures, and the NVIDIA Inception Program. As a private company, EarSwitch is focused on developing and marketing potentially life-saving technologies, taking products through clinical trials, and connecting with potential licensees to maximize positive societal impact. Its dual focus on medical monitoring and human-device interaction positions it at the intersection of digital health, assistive technology, and inclusive medical diagnostics.

EarSwitch Ltd. was founded by Dr Nick Gompertz, a clinician whose experiences with patients suffering from motor neurone disease (ALS) inspired him to develop a non-intrusive, in-ear device that could help people with neurological impairments communicate and control their environment. The initial concept was a communications device that worked by detecting the tensing of a middle ear muscle. During development, Gompertz discovered that the ear offered far broader potential, including the ability to record real-world data from a site close to the eardrum. This realization led to the expansion of EarSwitch's technology platform beyond assistive communication into medical monitoring and diagnostics. The company developed a suite of in-ear biometric control and sensor technologies, branded as EarMetrics®, which are licensable to partners. EarMetrics® is designed to generate medical-grade insights that inform clinical decisions, empower personal health, and accelerate the development of new treatments. The company also announced the EarMetrics® Cloud, a secure cloud architecture intended to store contextual, racially inclusive, and structured digital biomarkers, supporting applications such as Hospital at Home, remote patient monitoring, in-hospital care, and clinical research. EarSwitch has grown to a team of 14 people based at its headquarters in Bristol, United Kingdom, comprising doctors, scientists, developers, engineers, and industry experts. The company has secured support from multiple academic, clinical, and commercial partners, including the NHS Clinical Entrepreneurs Programme, the Innovative Devices Access Pathway (IDAP), Praetura Ventures, and the NVIDIA Inception Program. These partnerships help fund development, conduct clinical trials, and connect EarSwitch with potential licensees. The company's vision is to redesign the future of healthcare through in-ear experiences, with a focus on capturing credible and interoperable health data, enabling racially inclusive oximetry, and augmenting human-to-environment experiences. As a private company, EarSwitch continues to develop and market its technologies, aiming to make a significant positive impact on society.

• Founded by Dr Nick Gompertz, inspired by experiences with ALS patients.

• Developed initial in-ear communications device concept based on middle ear muscle tension.

• Expanded technology platform to include medical monitoring and diagnostics, branded as EarMetrics®.

• Announced EarMetrics® Cloud for secure storage of digital biomarkers.

• Secured partnerships with NHS Clinical Entrepreneurs Programme, IDAP, Praetura Ventures, and NVIDIA Inception Program.

EarSwitch positions itself as a pioneer in in-ear biometric technology, aiming to provide a new global standard of medical monitoring and transform healthcare through racially inclusive oximetry, connected care, and augmented human-to-environment experiences.

• EarMetrics®

  A suite of licensable, in-ear biometrics hardware and technology that generates medical-grade insights to inform clinical decisions, empower personal health, and accelerate the development of new treatments.

• EarMetrics® Cloud

  A responsible cloud architecture designed to securely store contextual, racially inclusive, and structured digital biomarkers, with applications in Hospital at Home, remote patient monitoring, in-hospital care, and clinical research.

1. 1EarSwitch™ | in-ear technologyearswitch.co.uk
2. 2Creating a more inclusive future of healthcare | EarSwitch®earswitch.co.uk
3. 3EarSwitch Ltd. (United Kingdom) - Wikidatawikidata.org